再発または難治性の血液悪性腫瘍の臨床試験
合計8575件
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.募集
-
National University Hospital, Singaporeわからない
-
Blueprint Medicines Corporation完了肥満細胞性白血病 | 攻撃的な全身性肥満細胞症 | 全身性肥満細胞症関連の血液学的非マスト細胞疾患 | 再発または難治性骨髄性悪性腫瘍アメリカ, イギリス
-
Amsterdam UMC, location VUmcZonMw: The Netherlands Organisation for Health Research and Development; FondsNutsOhra完了
-
Julie-An M. TalanoMiltenyi Biotec, Inc.積極的、募集していない
-
Seoul National University HospitalMinistry of Health, Republic of Korea; The Korea Health Technology R&D Project through the Korea...わからない
-
Yale UniversityHospira, now a wholly owned subsidiary of Pfizer完了
-
Sidney Kimmel Cancer Center at Thomas Jefferson...完了
-
Baylor College of MedicineThe Methodist Hospital Research Institute終了しました
-
H. Lee Moffitt Cancer Center and Research Institute完了
-
Catholic University of the Sacred HeartPagano L, Aversa F, Locatelli F, Nosari A,Rossi G, Viale P完了
-
Bellicum Pharmaceuticals引きこもった骨髄異形成症候群 | 白血病 | 多発性骨髄腫 | リンパ腫 | その他の高リスクの血液悪性腫瘍
-
Gilead SciencesCalifornia Institute for Regenerative Medicine (CIRM)完了
-
University College, London一時停止
-
IRCCS Azienda Ospedaliero-Universitaria di Bologna募集
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.まだ募集していません
-
Duke UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)募集
-
Memorial Sloan Kettering Cancer Center完了
-
Maisonneuve-Rosemont HospitalCanadian Institutes of Health Research (CIHR); Hopital de l'Enfant-Jesus; St. Justine's Hospital; Canadian Cancer Society (CCS) と他の協力者完了
-
Celgene Corporationわからない
-
Fate Therapeutics終了しました
-
Loyola UniversityGamida Cell ltd完了
-
St. Jude Children's Research HospitalGenzyme, a Sanofi Company完了
-
Dana-Farber Cancer InstituteMiltenyi Biomedicine GmbH完了
-
Indiana University School of MedicineGenzyme, a Sanofi Company完了
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; Amgen完了
-
Brigham and Women's HospitalDana-Farber Cancer Institute; Robert Wood Johnson Foundation; American Society of Hematology募集